Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Orthopedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ann Surg Oncol. 2018 May;25(5):1153-1159. doi: 10.1245/s10434-018-6343-7. Epub 2018 Mar 1.
Artificial neural networks (ANNs) have been applied to many prediction and classification problems, and could also be used to develop a prediction model of survival outcomes for cancer patients.
The aim of this study is to develop a prediction model of survival outcomes for patients with gastric cancer using an ANN.
This study enrolled 1243 patients with stage IIA-IV gastric cancer who underwent D2 gastrectomy from January 2007 to June 2010. We used a recurrent neural network (RNN) to make the survival recurrent network (SRN), and patients were randomly sorted into a training set (80%) and a test set (20%). Fivefold cross-validation was performed with the training set, and the optimized model was evaluated with the test set. Receiver operating characteristic (ROC) curves and area under the curves (AUCs) were evaluated, and we compared the survival curves of the American Joint Committee on Cancer (AJCC) 8th stage groups with those of the groups classified by the SRN-predicted survival probability.
The test data showed that the ROC AUC of the SRN was 0.81 at the fifth year. The SRN-predicted survival corresponded closely with the actual survival in the calibration curve, and the survival outcome could be more discriminately classified by using the SRN than by using the AJCC staging system.
SRN was a more powerful tool for predicting the survival rates of gastric cancer patients than conventional TNM staging, and may also provide a more flexible and expandable method when compared with fixed prediction models such as nomograms.
人工神经网络 (ANN) 已被应用于许多预测和分类问题,也可用于开发癌症患者生存结果的预测模型。
本研究旨在使用 ANN 开发一种预测胃癌患者生存结果的模型。
本研究纳入了 2007 年 1 月至 2010 年 6 月接受 D2 胃切除术的 1243 例 IIA-IV 期胃癌患者。我们使用递归神经网络 (RNN) 构建生存递归网络 (SRN),并将患者随机分为训练集 (80%) 和测试集 (20%)。使用训练集进行五重交叉验证,使用测试集评估优化模型。评估了接收器工作特征 (ROC) 曲线和曲线下面积 (AUC),并比较了第 8 届美国癌症联合委员会 (AJCC) 分期组和 SRN 预测生存概率分类组的生存曲线。
测试数据显示,SRN 的 ROC AUC 在第 5 年为 0.81。SRN 预测的生存与校准曲线中的实际生存非常吻合,并且与 AJCC 分期系统相比,SRN 可以更准确地对生存结果进行分类。
SRN 是一种比传统 TNM 分期更强大的预测胃癌患者生存率的工具,与诸如列线图等固定预测模型相比,它也可能提供更灵活和可扩展的方法。